Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether Normobaric Oxygen can help people with Psychosis, Schizophrenia, or First-episode Psychosis. Participants take part in Normobaric Oxygen and complete follow-up assessments.
This study is comparing 3 Minute iTBS to the L DLPFC with Precision Brain Stimulation for Cannabis Users with Healthy Controls for people with Cannabis Use, Schizophrenia, Psychosis, or Rtms. Participants receive 3 Minute iTBS to the L DLPFC or Precision Brain Stimulation for Cannabis Users with Healthy Controls and complete study visits and assessments.
This study is looking at whether Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) can help people with Schizophenia Disorder or schizoaffective disorder. Participants take part in Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Schizophrenia and Predominant Negative Symptoms. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia Disorders. Taking part may give some people access to Music video game, but direct benefit is not guaranteed.
This study is looking at whether a mental health workshop can help people with psychosis, Psychiatric Hospitalization, or Engagement. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at be the first to comprehensively examine the health impact of social isolation in SZ for people with Schizophrenia and Related Disorders. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether a digital support tool can help people with Cognition or Healthy Participants. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Diroximel fumarate (DRF) with placebo for people with Schizophrenia Disorders. Participants receive Diroximel fumarate (DRF) or placebo and complete study visits and assessments.
This study is looking at examine how the human thalamus supports flexible thinking and behavior for people with Schizophrenia or Attention Deficit Disorder With Hyperactivity. Some participants may receive Within subject manipulation of working memory, cognitive control, and decision making instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing repetitive transcranial magnetic stimulation (active) with sham rTMS for people with Schizophrenia. Participants receive repetitive transcranial magnetic stimulation (active) or sham rTMS and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Emraclidine with placebo for people with Schizophrenia. Participants receive Emraclidine or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive active, then sham Intermittent Theta Burst Stimulation (iTBS) over DLPFC instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing Empagliflozin with Group 1 as control group for people with Sodium-glucose Transport Protein Two Inhibitor,Metabolic Deficits Caused by Antipsychotics. Participants receive Empagliflozin or Group 1 as control group and complete study visits and assessments.
This study is looking at whether Personalised medication advice based on pharmacogenetic testing can help people with anxiety or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether PEERS social skills intervention can help people with Autism Spectrum Disorder, Psychosis, or Social Communication. Participants take part in PEERS social skills intervention and complete follow-up assessments.
This study is looking at whether Magnetic Seizure Therapy (MST) can help people with Treatment Resistant Schizophrenia, Schizophrenia, or schizoaffective disorder. Participants take part in Magnetic Seizure Therapy (MST) and complete follow-up assessments.
This study is looking at care and outcomes for people with Heat Stress, Physiological Stress, or Cognitive Change. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether maintenance electroconvulsive therapy (mECT) can help people with Schizophrenia or Treatment Resistant Schizophrenia. Participants take part in maintenance electroconvulsive therapy (mECT) and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia Disorder. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether Clay therapy can help people with Schizophrenia and Related Disorders. Participants take part in Clay therapy and complete follow-up assessments.